Selective multifaceted E3 ubiquitin ligases barricade extreme defense: Potential therapeutic targets for neurodegeneration and ageing
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 24, 138-159
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Government of India
- Ramalinganswami Fellowship
- Innovative Young Biotechnologist Award (IYBA)
- Department of Biotechnology, Government of India
- Council of Scientific and Industrial Research-University Grants Commission (CSIR-UGC)
This publication has 371 references indexed in Scilit:
- Assessment of Proteasome Impairment and Accumulation/Aggregation of Ubiquitinated Proteins in Neuronal Cultures2011
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- Human ITCH E3 Ubiquitin Ligase Deficiency Causes Syndromic Multisystem Autoimmune DiseaseThe American Journal of Human Genetics, 2010
- Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulumBiochemical and Biophysical Research Communications, 2009
- The ubiquitin proteasome system in neuropathologyActa Neuropathologica, 2009
- The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer DevelopmentCancer Cell, 2008
- NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTENCell, 2007
- Distinct Ubiquitin-Ligase Complexes Define Convergent Pathways for the Degradation of ER ProteinsCell, 2006
- Angelman syndrome 2005: Updated consensus for diagnostic criteriaAmerican Journal of Medical Genetics Part A, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004